Many of the countries where most of the cases occur; put these treatments out of reach for many patients because of its complexity. The new drug, fexindazole, is a much simpler treatment in which it can be taken as a once-a-day pill for 10 days without having to be hospitalized. After the DNDi (Drugs for Neglected Diseases Initiative), a nonprofit organization, teamed up with drug maker Sanofi, they could test the drug on patients and apply for an EMA recommendation for the drug itself. The EMA has just recently approved of the drug and have expressed a “positive opinion” for the fexindazole, opening opportunities for patients to receive treatment earlier and help slow the spread of the disease as well.
Recent comments